05-11-2021 16:30 via medpagetoday.com

FDA Panel Shows Little Love for Prader-Willi Drug Candidate

(MedPage Today) -- An investigational carbetocin nasal spray for treating extreme hunger and other symptoms of Prader-Willi syndrome (PWS), a rare genetic disorder, received a near-unanimous thumbs-down from FDA advisors on Thursday.
In a 12-1...
Read more »